NASDAQ:CABA | Free Cash Flow | Cabaletta Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$42.56M$0.00-$42.56M
2025-12-31-$35.34M$205,000.00-$35.55M
2025-03-31-$30.8M$785,000.00-$31.59M
2024-12-31-$23.12M$376,000.00-$23.5M
2024-03-31-$23.99M$812,000.00-$24.8M
2023-12-31-$16.45M$185,000.00-$16.63M
2023-03-31-$12.61M$380,000.00-$12.99M
2022-12-31-$12.13M$316,000.00-$12.45M
2022-03-31-$12.81M$147,000.00-$12.96M
2021-12-31-$10.52M$151,000.00-$10.67M
2021-03-31-$8.67M$97,000.00-$8.77M
2020-12-31-$9.17M$227,000.00-$9.4M
2020-03-31-$4.93M$226,000.00-$5.16M
2019-12-31-$7.88M$273,000.00-$8.16M
2019-03-31-$2.27M$180,000.00-$2.45M
2018-12-31-$1.91M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$131.08M$1.23M-$132.31M
2024-12-31-$88.22M$2.21M-$90.43M
2023-12-31-$53.55M$687,000.00-$54.24M
2022-12-31-$46.38M$2.45M-$48.83M
2021-12-31-$34.11M$1.17M-$35.28M
2020-12-31-$26.77M$635,000.00-$27.41M
2019-12-31-$16.05M$693,000.00-$16.74M
2018-12-31-$4.66M